Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial [Phase 3]
A multicenter Phase 3 trial evaluating chemoradiotherapy plus anti-PD1 in recurrent nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma is curre…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating neoadjuvant and adjuvant tislelizumab for nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating chemotherapy plus loco-regional radiotherapy with toripalimab for de novo metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase III trial evaluating camrelizumab in combination with chemotherapy for recurrent/metastatic nasopharyngeal carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC [Phase 2, Phase 3]
Phase II/III randomized trial evaluating concurrent chemoradiotherapy with or without TNF for nasopharyngeal carcinoma is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study [Phase 2]
Phase 2 trial evaluating sintilimab with chemotherapy and radiotherapy in newly diagnosed metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy [Phase 2]
Phase 2 trial evaluating the combination of fluzoparib and camrelizumab in nasopharyngeal carcinoma that progressed after first-line chemoth…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing nedaplatin with cisplatin for nasopharyngeal carcinoma; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Nedaplatin in Treatment for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update for nedaplatin in treating nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update investigating adjuvant sintilimab plus capecitabine in nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating carbon-ion radiotherapy plus camrelizumab for locally recurrent nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. [Phase 2]
Phase 2 clinical trial evaluating intensity-modulated radiotherapy (IMRT) combined with toripalimab in unresectable locally recurrent nasoph…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating metronomic capecitabine with or without a PD-1 antibody as adjuvant therapy for high-risk nasopharyngeal carcinoma;…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial exploring PD-1 blockade and bevacizumab as a substitute for cisplatin in locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-18Clinical Trial Update: The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer [Phase 3]
This entry reports the results of a Phase 3 study evaluating toripalimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating anti-EGFR therapy with IMRT concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma resistant to…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating immunotherapy combined with chemotherapy in unresectable recurrent loco-regionally advanced nasopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC [Phase 3]
Phase 3 trial evaluating sequential or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin [Phase 2]
Phase 2 trial updating chemoradiotherapy with raltitrexed-cisplatin for locally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing Endostar plus intensity-modulated radiotherapy to chemoradiation for nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating anlotinib in combination with chemoradiation for locally advanced nasopharyngeal carcinoma; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: PD-1 Inhibitor Plus G-CSF in Recurrent/Metastatic NPC With First-line Treatment Failure [Phase 2]
Phase 2 trial update evaluating a PD-1 inhibitor with G-CSF as first-line treatment failure in recurrent/metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Endostar in combination with corticosteroids for radiation-induced brain necrosis in nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating niraparib plus sintilimab in recurrent/metastatic nasopharyngeal carcinoma.